Nvidia, one of the hottest companies in the AI boom, has attracted attention from the outside world. Recently, Nvidia submitted an investment target document, although there are not many companies invested, but most of them are related to the field of AI intelligence, and the news also inspired the stock prices of these companies. CNBC pointed out that Nvidia has long been involved in venture capital, and in view of the vigorous development of artificial intelligence, Nvidia's recent investment transactions are even more important, and investors want to get a piece of the pie.
Nvidia invests in publicly traded companies, including ARM, Recursion Pharmaceuticals, Soundhound AI, as well as Nano-X Imaging and TuSimple Future (TU***).
Among them, Soundhound is the best recognition software, which can handle artificial intelligence to process speech and voice recognition, and Nvidia has invested about $3.7 million in shares. Nvidia's investment in Soundhound originated in 2017, when Soundhound raised about $75 million from Nvidia and Samsung.
Nano-X uses artificial intelligence in medical imaging, and Nvidia has invested about $380,000 in shares. The report pointed out that the origin of Nvidia's investment in Nano was Nvidia's venture capital in Zebra Medical, an Israeli medical imaging start-up, many years ago, and Nano-X acquired Zebra in 2021
Nvidia invested in TuSimple's IPO in 2017 and now holds about $3 million in shares.
As for the biotech company Recursion, Nvidia acquired the company in 2023 through a public equity private investment (PIPE), buying a $50 million stake and the investment is currently valued at $76 million.
Save brick-and-mortar bookstores